Are Science and Technology Governable?

A small group of scientists and scholars sat around a coffee table recently, balancing lunches on laps while discussing the prospects of greatly extending human life using new genetics tools and nanotechnologies. The group included a Johns Hopkins University cancer biologist, a Yale University philosopher, the executive director of an Oakland, Calif.-based advocacy group focusing on genetics and society, a Washington lobbyist, and various others. The talk, about the societal implications of lif

Written byBilly Goodman
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The talk, about the societal implications of life extension, was occasionally difficult—and not just because of the divergent views. The discussion was taking place under the 105-foot dome of what once was the main reading room of Columbia University's Low Library (now an administration building). The cavernous space, designed precisely to quiet stray noise, made conversations across the coffee table difficult.

Moreover, nearly a dozen similar groups were scattered about the floor and adding to the general susurration as they discussed topics such as the alienation of scientists from policy or the need for science literacy in policymaking. The occasion was an unusual conference, Living with the Genie: Governing scientific and technological transformation in the 21st century (www.livingwiththegenie.org). Cosponsored by Columbia's Washington, DC-based Center for Science, Policy & Outcomes (CSPO) and the Funders' Working Group on Emerging Technologies, the March 5-7 meeting was not intended to lead to answers to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies